Solenis Acquires Nopco Colombiana

(c) Lichtmeister/Shutterstock
(c) Lichtmeister/Shutterstock

Following an agreement signed in May, US specialty chemical company Solenis has completed the acquisition of Nopco Colombiana. Financial details were not disclosed.  Headquartered in Medellin, Colombia, Nopco Colombiana was originally Solenis’ pulp and paper specialty chemical distributor in Central and South America.

The South American company is a leading producer and supplier of specialized chemical solutions for water-intensive industries such as pulp and paper, oil and gas, food and beverage, among others. Its products include wet strength resins, antiscalants, dispersants and defoamers, which are supplied to markets in Colombia, Ecuador and Peru.

“This acquisition represents Solenis’ commitment to direct channel investments in strategic growth markets. The addition of Nopco Colombiana allows the US firm to expand its capabilities to serve the growing process and water-treatment markets in Central and South America,” said John Panichella, president and CEO of Solenis, said.

The deal follows Solenis’ acquisition of Nopco Holding, a Norwegian producer of specialty chemicals for the pulp and paper industry, in September 2016.

Solenis was formerly known as Ashland Water Technologies. The name change coincided with the acquisition of Ashland Water Technologies in July 2014 by a fund managed by private equity company Clayton, Dubilier & Rice for around $1.8 billion. Solenis said it is focused on growing the business in the areas of process and water technologies.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.